Scopia Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,167,886	Closed	-$88.4M	–	35
2017 Q2	$88.4M	Sell	1,167,886 -697,737	-37%	-$52.8M	1.82%	23
2017 Q1	$123M	Buy	1,865,623 +1,031,345	+124%	+$68.1M	2.28%	15
2016 Q4	$52.9M	Buy	+834,278	New	+$52.9M	1%	24